Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

Nocturne Gaetane; Seror Raphaele; Mariette Xavier

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

【24h】

Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

机译：用TNF抑制剂治疗的RA患者淋巴瘤的风险根据组织学亚型和TNF抑制剂的类型而不同吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2017年第2期|共2页
作者
Nocturne Gaetane; Seror Raphaele; Mariette Xavier;
展开▼
作者单位

Hop Univ Paris Sud AP HP 78 Rue Gen Leclerc F-94270 Le Kremlin Bicetre France;

Hop Bicetre AP HP Dept Rheumatol Le Kremlin Bicetre France;

Hop Univ Paris Sud AP HP 78 Rue Gen Leclerc F-94270 Le Kremlin Bicetre France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor? [J] . Nocturne Gaetane, Seror Raphaele, Mariette Xavier Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2017,第2期

机译：用TNF抑制剂治疗的RA患者淋巴瘤的风险根据组织学亚型和TNF抑制剂的类型而不同吗？
2. Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-alpha (TNF-alpha) Targeted Biologics and Recently Licensed TNF-alpha Inhibitors: Data from Clinical Trials and National Registries [J] . Cantini Fabrizio, Niccoli Laura, Goletti Delia The Journal of rheumatology . 2014,第Suppla91期

机译：非靶向肿瘤坏死因子-α（TNF-alpha）靶向生物药和最近获得许可的TNF-α抑制剂治疗的患者的结核病风险：来自临床试验和国家注册的数据
3. Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-alpha (TNF-alpha) Targeted Biologics and Recently Licensed TNF-alpha Inhibitors: Data from Clinical Trials and National Registries [J] . Cantini Fabrizio, Niccoli Laura, Goletti Delia The Journal of rheumatology . 2014,第Suppla91期

机译：用非抗肿瘤坏死因子-α（TNF-α）靶向生物学和最近授权的TNF-α抑制剂治疗的患者的肺结核风险：来自临床试验和国家注册管理机构的数据
4. Correlation of the MMP-9 and Inhibitor-1, TNF-A and Bone Mineral Density in Patients with Chronic Obstructive Pulmonary Disease [C] . Ying Xu International Conference on Frontiers of Biological Sciences and Engineering . 2019

机译：慢性阻塞性肺疾病患者MMP-9和抑制剂-1，TNF-A和骨密度的相关性
5. Antipsychotic Compounds Inhibit Inflammatory Stimulation of TNFα from Microglia: Relevance to Hemorrhagic Stroke, Alzheimer’s Disease and Other Inflammatory Diseases [D] . Vicari, James Michael 2019

机译：抗精神病化合物抑制小胶质细胞的TNFα的炎症刺激：与出血性中风，阿尔茨海默氏病和其他炎症性疾病的相关性
6. Case Report: Synchronous colonic lymphoma and adenocarcinoma in a patient with Crohns disease treated with thiopurine therapy and a TNFα inhibitor: a challenge to Occams razor [O] . Rowan Daniel Beaumont Bell, Kieran John Moriarty 2016

机译：病例报告：克罗恩病患者的同步结肠淋巴瘤和腺癌用硫嘌呤治疗和TNFα抑制剂治疗：对Occam剃刀的挑战
7. Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor? [O] . Gaetane Nocturne, Raphaele Seror, Xavier Mariette 2016

机译：用TNF抑制剂治疗的RA患者淋巴瘤的风险根据组织学亚型和TNF抑制剂的类型而不同吗？

Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

著录项

相似文献

相关主题

期刊订阅